MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the…
admin
-
-
The Government of Ontario started taking applications for resource development projects under its “One Project, One Process” framework on Friday (October 17). The new process, which Ontario lawmakers introduced in the spring, promises to streamline…
-
Investing
Tech Weekly: Broadcom and OpenAI Sign Deal, AMD and Oracle Announce Partnership
by adminby adminThis week was marked by strong, event-driven volatility across the tech sector. Market moves were shaped by artificial intelligence (AI) infrastructure announcements, semiconductor earnings, signals of macroeconomic stress and escalating tensions between the US and…
-
Investing
Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units
by adminby admin/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ finlay minerals ltd. (TSXV: FYL,OTC:FYMNF) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’) is pleased to announce that it has closed its non-brokered private placement…
-
MILAN — Giorgio Armani has appointed deputy managing director Giuseppe Marsocci as chief executive with immediate effect, the Italian fashion house said on Thursday, confirming media reports. Marsocci, who has been with the company for…
-
-
Don Durrett of GoldStockData.com outlines current gold and silver market dynamics, explaining why the metals continue to rise and how high they could go in the future. He also shares his current gold and silver…
-
-
-
It’s been yet another historic week for gold and silver, with both setting new price records. The yellow metal broke through US$4,200 per ounce and then continued on past US$4,300. It rose as high as…